VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

Alphabet Inc.'s Holding History (CIK: 0001652044)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 12,168,489 Value ($000) $136,652 Avg Close — Range —
Q1 2025
Shares 12,349,086 Value ($000) $56,435 Avg Close — Range —
Q4 2024
Shares 12,349,086 Value ($000) $69,647 Avg Close — Range —
Q3 2024
Shares 12,349,086 Value ($000) $59,770 Avg Close — Range —
Q2 2024
Shares 12,349,086 Value ($000) $60,264 Avg Close — Range —
Q1 2024
Shares 12,349,086 Value ($000) $163,996 Avg Close — Range —
Q4 2023
Shares 12,349,086 Value ($000) $172,146 Avg Close — Range —
Q3 2023
Shares 10,549,086 Value ($000) $139,881 Avg Close — Range —
Q2 2023
Shares 10,549,086 Value ($000) $197,795 Avg Close — Range —
Q1 2023
Shares 10,549,086 Value ($000) $152,118 Avg Close — Range —
Q4 2022
Shares 10,549,086 Value ($000) $204,125 Avg Close — Range —
Q3 2022
Shares 10,974,011 Value ($000) $376,958 Avg Close — Range —
Q2 2022
Shares 10,974,011 Value ($000) $167,683 Avg Close — Range —
Q1 2022
Shares 10,974,011 Value ($000) $250,427 Avg Close — Range —
Q4 2021
Shares 10,974,011 Value ($000) $404,612 Avg Close — Range —
Q3 2021
Shares 10,974,011 Value ($000) $515,778 Avg Close — Range —
Q2 2021
Shares 10,974,011 Value ($000) $661,184 Avg Close — Range —